CorFlow’s CoFI System secures FDA breakthrough device status for coronary microcirculation
The breakthrough device designation for the CoFI System is for assessing the coronary microcirculation immediately after stenting
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Oct 19
The breakthrough device designation for the CoFI System is for assessing the coronary microcirculation immediately after stenting
BT has unveiled plans behind the deployment of its 5G network in industries including healthcare, broadcasting and retail
18 Oct 19
The alliance provides patients, physicians with understandable and actionable information of risk factors associated with stroke and other…
Healthy.io has been granted FDA clearance and raised $78m in investment to date
30 Sep 19
The new research facility focuses on data analytics and clinical trial management to promote the clinical development of…
23 Sep 19
The test detects the four different species of Babesia parasites capable of causing disease in humans employing new…
23 Sep 19
Zimmer Biomet Dental has rolled out iTero Element scanners and services in selected countries in Europe and is…
12 Sep 19
The new Stellant FLEX is offered in 150mL and 200mL syringe sizes, with new beacon technology for easy…
12 Sep 19
Healthy.io has designed the test for pharmacies, urgent care centres, or health clinics to perform the test without…
Mobile health technologies could improve the efficiency, speed and interconnectedness of an integrated clinical and public health response